Literature DB >> 2266048

Serosurvey of horses with evidence of equine monocytic ehrlichiosis.

Y Rikihisa1, S M Reed, R A Sams, J C Gordon, C I Pretzman.   

Abstract

In August 1986, an extensive serosurvey for prevalence of IgG and IgM antibodies against Ehrlichia risticii, the causative agent of equine monocytic ehrlichiosis (EME), was performed at 2 Ohio racetracks, River Downs (RD) and Beulah Park (BP). Of 840 horses at RD and 574 at BP, 13 and 20%, respectively, were IgG antibody-positive (by indirect fluorescent antibody test results), with antibody titer ranging from 1:20 to 1:10,240. The titer observed at highest frequency at both racetracks was 1:80. A higher proportion of horses was ill at RD (operating during the summer months) than at BP (winter track). Of ill horses, 41% (24/58) at RD and 58% (11/19) at BP were seropositive. At RD, 70% (589/840) of all horses and 95% (102/107) of IgG seropositive horses had been stabled only at RD during the month prior to testing. Analysis of these sera by use of an ELISA to detect IgM antibody against E risticii antigen indicated that at RD, 42% (57/137) of the seropositive horses were IgM seropositive. At BP, 17% (20/120) of seropositive horses were IgM seropositive. The larger number of IgM seropositive horses at RD indicates that more horses were recently infected at RD than at BP (P = 0.0001). Therefore, at least half the seropositive horses at RD seemed to have acquired the infection at RD. These serosurvey data also indicate that at BP and RD, 78% (85/109) and 91% (111/122) of IgG seropositive horses, respectively, had subclinical infection. At less than or equal to 1:40 titer, there was no difference in seropositive rates between healthy and ill horses.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266048

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  6 in total

1.  Comparison of PCR and culture to the indirect fluorescent-antibody test for diagnosis of Potomac horse fever.

Authors:  J Mott; Y Rikihisa; Y Zhang; S M Reed; C Y Yu
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and -negative human sera by using native and recombinant E. chaffeensis and E. canis antigens.

Authors:  A Unver; Y Rikihisa; N Ohashi; L C Cullman; R Buller; G A Storch
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

3.  Inhibition of binding, entry, or intracellular proliferation of Ehrlichia risticii in P388D1 cells by anti-E. risticii serum, immunoglobulin G, or Fab fragment.

Authors:  J B Messick; Y Rikihisa
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 4.  The tribe Ehrlichieae and ehrlichial diseases.

Authors:  Y Rikihisa
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Antigenic, morphologic, and molecular characterization of new Ehrlichia risticii isolates.

Authors:  W Chaichanasiriwithaya; Y Rikihisa; S Yamamoto; S Reed; T B Crawford; L E Perryman; G H Palmer
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

6.  Neorickettsia risticii surface-exposed proteins: proteomics identification, recognition by naturally-infected horses, and strain variations.

Authors:  Kathryn E Gibson; Gabrielle Pastenkos; Susanne Moesta; Yasuko Rikihisa
Journal:  Vet Res       Date:  2011-06-02       Impact factor: 3.683

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.